| David B Andrews, PT | |
|
1101 E Polston Ave, Suite A, Post Falls, ID 83854-6045 | |
| (208) 773-8111 | |
| (208) 773-8385 |
| Full Name | David B Andrews |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 37 Years |
| Location | 1101 E Polston Ave, Post Falls, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356361406 | NPI | - | NPPES |
| 1356361406-000 | Medicaid | ID | |
| 1356361406 | Medicaid | WA | |
| 804123800 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT-1049 (Idaho) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shellman Inc Pa | 4981592938 | 32 |
News Archive
A high-dose of ultrasound targeted to painful bone metastases appears to quickly bring patients relief, and with largely tolerable side effects, according to new research presented by Fox Chase Cancer Center scientists at the 49th Annual Meeting of the American Society of Clinical Oncology on Monday, June 3.
The John Theurer Cancer Center at Hackensack University Medical Center and The Leukemia & Lymphoma Society have come together to host Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers on Tuesday, June 22 in Hackensack, NJ. This free educational program is for patients, caregivers, and healthcare providers.
Vertex Pharmaceuticals Incorporated today announced results from the Phase 3 ILLUMINATE study, which was designed to evaluate whether there was any benefit to extending therapy from 24 to 48 weeks in people whose hepatitis C virus (HCV) was undetectable at weeks 4 and 12 of treatment (extended rapid viral response or eRVR).
Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance, today announced the release of Therapeutic Area Essentials™, a comprehensive suite of more than 155 therapeutic area e-courses covering diagnosis, cause, and treatment for over 40 disease states.
Over 5000 patients with metastatic melanoma in Europe are denied access to new, life saving drugs every year, according to a survey presented at the ESMO 2016 Congress in Copenhagen.
› Verified 1 days ago
| Provider Name | Shellman Inc Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326050253 PECOS PAC ID: 4981592938 Enrollment ID: O20040310000340 |
News Archive
A high-dose of ultrasound targeted to painful bone metastases appears to quickly bring patients relief, and with largely tolerable side effects, according to new research presented by Fox Chase Cancer Center scientists at the 49th Annual Meeting of the American Society of Clinical Oncology on Monday, June 3.
The John Theurer Cancer Center at Hackensack University Medical Center and The Leukemia & Lymphoma Society have come together to host Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers on Tuesday, June 22 in Hackensack, NJ. This free educational program is for patients, caregivers, and healthcare providers.
Vertex Pharmaceuticals Incorporated today announced results from the Phase 3 ILLUMINATE study, which was designed to evaluate whether there was any benefit to extending therapy from 24 to 48 weeks in people whose hepatitis C virus (HCV) was undetectable at weeks 4 and 12 of treatment (extended rapid viral response or eRVR).
Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance, today announced the release of Therapeutic Area Essentials™, a comprehensive suite of more than 155 therapeutic area e-courses covering diagnosis, cause, and treatment for over 40 disease states.
Over 5000 patients with metastatic melanoma in Europe are denied access to new, life saving drugs every year, according to a survey presented at the ESMO 2016 Congress in Copenhagen.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David B Andrews, PT 1917 N Lakewood Dr, Coeur D Alene, ID 83814-2634 Ph: (208) 664-8194 | David B Andrews, PT 1101 E Polston Ave, Suite A, Post Falls, ID 83854-6045 Ph: (208) 773-8111 |
News Archive
A high-dose of ultrasound targeted to painful bone metastases appears to quickly bring patients relief, and with largely tolerable side effects, according to new research presented by Fox Chase Cancer Center scientists at the 49th Annual Meeting of the American Society of Clinical Oncology on Monday, June 3.
The John Theurer Cancer Center at Hackensack University Medical Center and The Leukemia & Lymphoma Society have come together to host Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers on Tuesday, June 22 in Hackensack, NJ. This free educational program is for patients, caregivers, and healthcare providers.
Vertex Pharmaceuticals Incorporated today announced results from the Phase 3 ILLUMINATE study, which was designed to evaluate whether there was any benefit to extending therapy from 24 to 48 weeks in people whose hepatitis C virus (HCV) was undetectable at weeks 4 and 12 of treatment (extended rapid viral response or eRVR).
Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance, today announced the release of Therapeutic Area Essentials™, a comprehensive suite of more than 155 therapeutic area e-courses covering diagnosis, cause, and treatment for over 40 disease states.
Over 5000 patients with metastatic melanoma in Europe are denied access to new, life saving drugs every year, according to a survey presented at the ESMO 2016 Congress in Copenhagen.
› Verified 1 days ago
Jesse Brouwer, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 104 W 9th Ave, Post Falls, ID 83854 Phone: 208-777-9740 Fax: 208-777-8316 | |
Matthew E Kifer, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 640 N Thornton St, Post Falls, ID 83854 Phone: 208-773-2888 Fax: 208-806-0222 | |
Sports Medicine Services Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 925 E Polston Ave, Post Falls, ID 83854 Phone: 208-772-8147 | |
Nathaniel Jay Delegard, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1610 E Schneidmiller Ave, Post Falls, ID 83854 Phone: 208-773-8111 | |
Ryan Neall, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 640 N Thornton St, Post Falls, ID 83854 Phone: 208-773-2888 Fax: 208-806-0222 | |
Mr. Ben John Baarspul, PHYSICAL THERAPIST Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 238 S Sequoia St, Post Falls, ID 83854 Phone: 503-704-2150 | |
Derrick Jay Webb, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1590 E Polston Ave, Post Falls, ID 83854 Phone: 208-777-4242 Fax: 208-777-4020 |